• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Orphalan announces NMPA™s approval of its trientine tetrahydrochloride product

    GLOBENEWSWIRE

    Orphalan announces US commercial launch of Cuvrior

    GLOBENEWSWIRE

    Orphalan announces publication of results from the CHELATE trial

    GLOBENEWSWIRE

    Orphalan announces enrolment in International Wilson`s Disease Patient Registry

    GLOBENEWSWIRE

    Orphalan announces data from secondary analyses of the CHELATE trial

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.